论文部分内容阅读
据美国国立卫生研究院和美国国立眼科研究所2002年6月13日发布的新闻报道,一项新的研究发现,用降低眼内压眼药水的高眼压者比未用者患青光眼的减省一半以上 美国22个临床中心的眼科学家对1,636名40～80岁的眼内压增高者进行了研究。研究结果显示,尽管眼药水只能将眼内压降低20％,但对预防青光眼的发病具有重要作用。在5年的研究期间,参与者使用眼药水的只有4.4％患上青光眼,而作为对照组,没用药者则有9.5％。研究还发现,老年人和黑人患青光眼的可能更大 另外,诸如眼压较高、视神经的解剖特点和角膜的厚度之类的因素都有助于预测哪些人可能患青光眼。研究人员还指出,并非所有眼压增高者均可用眼药水治疗。如果你有青光眼的危险因素.要到专业人士那里进行仔细眼部检查,以决定是否使用 专业眼科人员不应为所有眼压升高而没有青光眼迹象者使用眼药水,医生们应考虑多个因素,包括90％的参与者五年内没有患病的简单事实。美国国立眼科研究所主任西温(Paul Sieving)教授指出本实验为美国国立眼科研究所青光眼研究计划之一,他们将继续指导和支持这项研究,目的在于找到更好的发现、治疗及可能预防青光眼的新方法
According to the National Institutes of Health and the National Eye Institute news release on June 13, 2002, a new study found that patients with ocular hypertension who had lower intraocular pressure eye drops had less glaucoma than those who did not More than half of ophthalmologists from 22 clinical centers in the United States studied 1,636 patients with elevated intraocular pressure (IOP), 40 to 80 years of age. The results show that although eye drops can only reduce intraocular pressure by 20%, but the prevention of glaucoma plays an important role. During the five-year study, only 4.4% of participants who used eye drops had glaucoma, compared with 9.5% of those who did not. The study also found that older adults and blacks are more likely to have glaucoma. In addition, factors such as higher IOP, anatomical features of the optic nerve, and corneal thickness help predict who may have glaucoma. The researchers also pointed out that not all those with elevated intraocular pressure can be treated with eye drops. If you have a glaucomatous risk factor, you should go to a professional eye exam to determine whether to use professional ophthalmologist should not use eye drops for all patients with elevated intraocular pressure without signs of glaucoma, doctors should consider a number of factors , Including the simple fact that 90% of participants did not get sick within five years. Professor Paul Sieving, director of the National Institute of Ophthalmology, points out that the experiment is one of the National Eye Institute’s glaucoma research programs and will continue to guide and support the study with the aim of finding better discoveries, treatments, and possible prophylaxis A new method of glaucoma